Aussies are some of the most enthusiastic adopters of new clinical drugs. In 2019, 95,000 of us participated in nearly…
Having delivered impressive interim trial data from their Phase 2 clinical trials for a treatment targeting incurable bone marrow cancer,…
When it comes to biotech investing, the value opportunities in Australia attract many of the world's smartest investors. Amongst them,…
For patients given less than five years to live after being diagnosed with myelofibrosis, there is a new flicker of…
This morning’s announcement may have surprised many investors following the Pharmaxis (ASX: PXS) story because where on earth does Parkinson’s…